Intellia Therapeutics spent some 466 million U.S. dollars on research and development in 2024, compared to 11 million U.S. dollars back in 2015. Intellia is a biotech company from Massachusetts that produces therapeutics using CRISPR technology.
Research and development expenses of Intellia Therapeutics from 2014 to 2024
(in million U.S. dollars)
Characteristic
Expenses in million U.S. dollars
2024
466.31
2023
435.07
2022
419.98
2021
229.81
2020
150.41
2019
108.41
2018
89.12
2017
67.65
2016
31.84
2015
11.17
2014
1.11
0100200300400500600
Add this content to your personal favorites. These can be accessed from the favorites menu in the main navigation.
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Learn more about how Statista can support your business.
Intellia Therapeutics, & U.S. Securities and Exchange Commission. (February 27, 2025). Research and development expenses of Intellia Therapeutics from 2014 to 2024 (in million U.S. dollars) [Graph]. In Statista. Retrieved April 28, 2025, from https://www.statista.com/statistics/1097423/research-and-development-costs-for-intellia-therapeutics/
Intellia Therapeutics, und U.S. Securities and Exchange Commission. "Research and development expenses of Intellia Therapeutics from 2014 to 2024 (in million U.S. dollars)." Chart. February 27, 2025. Statista. Accessed April 28, 2025. https://www.statista.com/statistics/1097423/research-and-development-costs-for-intellia-therapeutics/
Intellia Therapeutics, U.S. Securities and Exchange Commission. (2025). Research and development expenses of Intellia Therapeutics from 2014 to 2024 (in million U.S. dollars). Statista. Statista Inc.. Accessed: April 28, 2025. https://www.statista.com/statistics/1097423/research-and-development-costs-for-intellia-therapeutics/
Intellia Therapeutics, and U.S. Securities and Exchange Commission. "Research and Development Expenses of Intellia Therapeutics from 2014 to 2024 (in Million U.S. Dollars)." Statista, Statista Inc., 27 Feb 2025, https://www.statista.com/statistics/1097423/research-and-development-costs-for-intellia-therapeutics/
Intellia Therapeutics & U.S. Securities and Exchange Commission, Research and development expenses of Intellia Therapeutics from 2014 to 2024 (in million U.S. dollars) Statista, https://www.statista.com/statistics/1097423/research-and-development-costs-for-intellia-therapeutics/ (last visited April 28, 2025)
Research and development expenses of Intellia Therapeutics from 2014 to 2024 (in million U.S. dollars) [Graph], Intellia Therapeutics, & U.S. Securities and Exchange Commission, February 27, 2025. [Online]. Available: https://www.statista.com/statistics/1097423/research-and-development-costs-for-intellia-therapeutics/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
